John Sieckhaus's most recent trade in Biosig Technologies Inc was a trade of 92,300 Common Stock done . Disclosure was reported to the exchange on Nov. 30, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biosig Technologies Inc | John Sieckhaus | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2023 | 92,300 | 457,920 (1%) | 0% | 0 | Common Stock | |
| Biosig Technologies Inc | John Sieckhaus | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 295,620 | 365,620 (1%) | 1% | 0 | Common Stock | |
| Biosig Technologies Inc | John Sieckhaus | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 0.91 per share. | 12 Sep 2022 | 5,000 | 70,000 (0%) | 0% | 0.9 | 4,550 | Common Stock |
| Biosig Technologies Inc | John Sieckhaus | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 1.07 per share. | 30 Aug 2022 | 5,000 | 65,000 (0%) | 0% | 1.1 | 5,335 | Common Stock |
| Biosig Technologies Inc | John Sieckhaus | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 1.13 per share. | 24 Aug 2022 | 10,000 | 60,000 (0%) | 0% | 1.1 | 11,347 | Common Stock |
| Biosig Technologies Inc | John Sieckhaus | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 350,000 | 350,000 | - | - | Options | |
| Biosig Technologies Inc | John Sieckhaus | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 50,000 | 50,000 (0%) | 0% | 0 | Common Stock |